Clinical Trial Update: Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning

View source ↗

Summary

A clinical trial update from UMC Utrecht examining how genetic risk for Attention Deficit Hyperactivity Disorder is expressed in brain functioning.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Snippet

Sponsor: UMC Utrecht | Conditions: Attention Deficit Hyperactivity Disorder | Status: UNKNOWN